{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:19:14Z","timestamp":1793125154052,"version":"4.5.0"},"reference-count":243,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Over the past two decades, Next-Generation Sequencing (NGS) has revolutionized the approach to cancer research. Applications of NGS include the identification of tumor specific alterations that can influence tumor pathobiology and also impact diagnosis, prognosis and therapeutic options. Pharmacogenomics (PGx) studies the role of inheritance of individual genetic patterns in drug response and has taken advantage of NGS technology as it provides access to high-throughput data that can, however, be difficult to manage. Machine learning (ML) has recently been used in the life sciences to discover hidden patterns from complex NGS data and to solve various PGx problems. In this review, we provide a comprehensive overview of the NGS approaches that can be employed and the different PGx studies implicating the use of NGS data. We also provide an excursus of the ML algorithms that can exert a role as fundamental strategies in the PGx field to improve personalized medicine in cancer.<\/jats:p>","DOI":"10.3389\/fphar.2023.1260276","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T04:12:51Z","timestamp":1704773571000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Machine learning in onco-pharmacogenomics: a path to precision medicine with many challenges"],"prefix":"10.3389","volume":"14","author":[{"given":"Alessia","family":"Mondello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Dal Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Toffoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Polano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1158\/1078-0432.CCR-13-3232","article-title":"Replication of genetic polymorphisms reported to Be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with paclitaxel","volume":"20","author":"Abraham","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1158\/1078-0432.CCR-20-3286","article-title":"Clinical validation of a machine-learning\u2013derived signature predictive of outcomes from first-line oxaliplatin-based chemotherapy in advanced colorectal cancer","volume":"27","author":"Abraham","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.3390\/cancers15164124","article-title":"A breast cancer polygenic risk score is feasible for risk stratification in the Norwegian population","volume":"15","author":"Akdeniz","year":"2023","journal-title":"Cancers"},{"key":"B4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1158\/2159-8290.CD-12-0502","article-title":"De-repression of PDGFR\u03b2 transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients","volume":"3","author":"Akhavan","year":"2013","journal-title":"Cancer Discov."},{"key":"B5","doi-asserted-by":"publisher","first-page":"16070","DOI":"10.3390\/ijms232416070","article-title":"Deep learning-based artificial intelligence to investigate targeted nanoparticles\u2019 uptake in TNBC cells","volume":"23","author":"Ali","year":"2022","journal-title":"IJMS"},{"key":"B6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrg3356","article-title":"Next-generation proteomics: towards an integrative view of proteome dynamics","volume":"14","author":"Altelaar","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/bioengineering10040396","article-title":"Tumor cellularity assessment of breast histopathological slides via instance segmentation and pathomic features explainability","volume":"10","author":"Altini","year":"2023","journal-title":"Bioengineering"},{"key":"B8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/cts.12869","article-title":"Pharmacogenomics biomarker discovery and validation for translation in clinical practice","volume":"14","author":"Arbitrio","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"100100","DOI":"10.1016\/j.xhgg.2022.100100","article-title":"From pharmacogenetics to pharmaco-omics: milestones and future directions","volume":"3","author":"Auwerx","year":"2022","journal-title":"Hum. Genet. Genomics Adv."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0208080","DOI":"10.1371\/journal.pone.0208080","article-title":"Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab","volume":"13","author":"Baas","year":"2018","journal-title":"PLoS ONE"},{"key":"B11","doi-asserted-by":"publisher","first-page":"112934","DOI":"10.1016\/j.ejca.2023.05.022","article-title":"Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-na\u00efve metastatic colorectal cancer. An AGEO prospective study","volume":"189","author":"Bachet","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.1038\/sj.onc.1208955","article-title":"Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs","volume":"24","author":"Baker","year":"2005","journal-title":"Oncogene"},{"key":"B13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/CAD.0000000000000596","article-title":"Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung","volume":"29","author":"Balasubramaniam","year":"2018","journal-title":"Anti-Cancer Drugs"},{"key":"B14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1200\/PO.20.00182","article-title":"Impact of a 40-gene targeted panel test on physician decision making for patients with acute myeloid leukemia","volume":"5","author":"Barnell","year":"2021","journal-title":"JCO Precis. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.20517\/2394-4722.2018.04","article-title":"Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectives","volume":"4","author":"Battaglin","year":"2018","journal-title":"JCMT"},{"key":"B16","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/cpt.2511","article-title":"Machine learning application in a phase I clinical trial allows for the identification of clinical-biomolecular markers significantly associated with toxicity","volume":"111","author":"Bedon","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/ng.601","article-title":"A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci","volume":"42","author":"Bei","year":"2010","journal-title":"Nat. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1073\/pnas.1418631112","article-title":"Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants","volume":"112","author":"Belkadi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.csbj.2019.10.004","article-title":"Applications and analysis of targeted genomic sequencing in cancer studies","volume":"17","author":"Bewicke-Copley","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1200\/JCO.2013.53.0808","article-title":"Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia","volume":"32","author":"Bhojwani","year":"2014","journal-title":"JCO"},{"key":"B21","doi-asserted-by":"publisher","first-page":"S510","DOI":"10.21037\/tcr.2018.03.36","article-title":"Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma","volume":"7","author":"Binder","year":"2018","journal-title":"Transl. Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10637-007-9075-2","article-title":"Phase II trial of the histone deacetylase inhibitor vorinostat (ZolinzaTM, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and\/or metastatic head and neck cancer","volume":"26","author":"Blumenschein","year":"2008","journal-title":"Invest. New Drugs"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41698-017-0010-5","article-title":"Precision oncology-the future of personalized cancer medicine?","volume":"1","author":"Bode","year":"2017","journal-title":"npj Precis. Onc"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1561\/2200000016","article-title":"Distributed optimization and statistical learning via the alternating direction method of multipliers","volume":"3","author":"Boyd","year":"2010","journal-title":"FNT Mach. Learn."},{"key":"B25","doi-asserted-by":"publisher","first-page":"18545","DOI":"10.1073\/pnas.1010978107","article-title":"Accumulation of driver and passenger mutations during tumor progression","volume":"107","author":"Bozic","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forest","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"key":"B27","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"107027","DOI":"10.1016\/j.cmpb.2022.107027","article-title":"Precise prediction of multiple anticancer drug efficacy using multi target regression and support vector regression analysis","volume":"224","author":"Brindha","year":"2022","journal-title":"Comput. Methods Programs Biomed."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"IJMS"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1038\/s41598-021-83102-6","article-title":"Deep learning identifies morphological features in breast cancer predictive of cancer ERBB2 status and trastuzumab treatment efficacy","volume":"11","author":"Bychkov","year":"2021","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"109842","DOI":"10.1016\/j.radonc.2023.109842","article-title":"Interpretable AI-assisted Clinical Decision Making (CDM) for dose prescription in radiosurgery of brain metastases","volume":"187","author":"Cao","year":"2023","journal-title":"Radiotherapy Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/jpm12040601","article-title":"Machine-learning-based late fusion on multi-omics and multi-scale data for non-small-cell lung cancer diagnosis","volume":"12","author":"Carrillo-Perez","year":"2022","journal-title":"JPM"},{"key":"B33","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/clpt.2013.172","article-title":"Clinical pharmacogenetics implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing","volume":"94","author":"Caudle","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.3390\/pharmaceutics14112509","article-title":"Machine-learning exploration of exposure-effect relationships of cisplatin in head and neck cancer patients","volume":"14","author":"Cauvin","year":"2022","journal-title":"Pharmaceutics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40487-018-0090-6","article-title":"The roles of common variation and somatic mutation in cancer pharmacogenomics","volume":"7","author":"Chan","year":"2019","journal-title":"Oncol. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"8857","DOI":"10.1038\/s41598-018-27214-6","article-title":"Cancer drug response profile scan (CDRscan): a deep learning model that predicts drug effectiveness from cancer genomic signature","volume":"8","author":"Chang","year":"2018","journal-title":"Sci. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7150\/ijbs.66913","article-title":"Integrated machine learning and bioinformatic analyses constructed a novel stemness-related classifier to predict prognosis and immunotherapy responses for hepatocellular carcinoma patients","volume":"18","author":"Chen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.3390\/cells12162042","article-title":"Spatial transcriptomic technologies","volume":"12","author":"Chen","year":"2023","journal-title":"Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2147\/BCTT.S423330","article-title":"Survival outcomes and efficacy of platinum in early breast cancer patients with germline BRCA1 or BRCA2 mutation: a multicenter retrospective cohort study","volume":"15","author":"Chen","year":"2023","journal-title":"BCTT"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e377","DOI":"10.1016\/j.crad.2022.12.013","article-title":"Deep learning for predicting the risk of immune checkpoint inhibitor-related pneumonitis in lung cancer","volume":"78","author":"Cheng","year":"2023","journal-title":"Clin. Radiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13014-022-02186-0","article-title":"Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures","volume":"17","author":"Cui","year":"","journal-title":"Radiat. Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1095059","DOI":"10.3389\/fonc.2022.1095059","article-title":"Development of a web-based calculator to predict three-month mortality among patients with bone metastases from cancer of unknown primary: an internally and externally validated study using machine-learning techniques","volume":"12","author":"Cui","year":"","journal-title":"Front. Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13045-022-01394-1","article-title":"miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response","volume":"15","author":"Cuttano","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"CD008792","DOI":"10.1002\/14651858.CD008792.pub2","article-title":"Combination versus sequential single agent chemotherapy for metastatic breast cancer","volume":"2013","author":"Dear","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/jop.13379","article-title":"Exosomal hsa_circRNA_047733 integrated with clinical features for preoperative prediction of lymph node metastasis risk in oral squamous cell carcinoma","volume":"52","author":"Deng","year":"2023","journal-title":"J. Oral Pathol. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s40262-023-01279-7","article-title":"Irinotecan-induced toxicity: a pharmacogenetic study beyond UGT1A1","volume":"62","author":"De With","year":"2023","journal-title":"Clin. Pharmacokinet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"780","DOI":"10.4161\/cbt.12.9.17781","article-title":"Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study","volume":"12","author":"Di Martino","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J. Health Econ."},{"key":"B50","first-page":"143","article-title":"Trends in hypersensitivity drug reactions: more drugs, more response patterns, more heterogeneity","volume":"24","author":"Do\u00f1a","year":"2014","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"8736","DOI":"10.1021\/acs.chemrev.3c00189","article-title":"Machine learning methods for small data challenges in molecular science","volume":"123","author":"Dou","year":"2023","journal-title":"Chem. Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"100492","DOI":"10.1016\/j.xcrm.2021.100492","article-title":"A community challenge for a pancancer drug mechanism of action inference from perturbational profile data","volume":"3","author":"Douglass","year":"2022","journal-title":"Cell Rep. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion\u2013positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr\u2013Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.celrep.2018.06.106","article-title":"mTORC1 upregulation leads to accumulation of the oncometabolite fumarate in a mouse model of renal cell carcinoma","volume":"24","author":"Drusian","year":"2018","journal-title":"Cell Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"56726","DOI":"10.18632\/oncotarget.11059","article-title":"Comparative proteomic profiling of refractory\/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy","volume":"7","author":"Dytfeld","year":"2016","journal-title":"Oncotarget"},{"key":"B58","doi-asserted-by":"publisher","first-page":"960984","DOI":"10.3389\/fonc.2022.960984","article-title":"Semi-supervised learning in cancer diagnostics","volume":"12","author":"Eckardt","year":"2022","journal-title":"Front. Oncol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s43856-023-00298-6","article-title":"Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles","volume":"3","author":"Eckardt","year":"2023","journal-title":"Commun. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.3390\/cancers13184624","article-title":"Reinforcement learning for precision oncology","volume":"13","author":"Eckardt","year":"2021","journal-title":"Cancers"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1158\/2159-8290.CD-13-0219","article-title":"Connecting genomic alterations to cancer biology with proteomics: the NCI clinical proteomic tumor analysis Consortium","volume":"3","author":"Ellis","year":"2013","journal-title":"Cancer Discov."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1158\/0008-5472.CAN-08-3907","article-title":"Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome","volume":"69","author":"Elsheikh","year":"2009","journal-title":"Cancer Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"115077","DOI":"10.1016\/j.biopha.2023.115077","article-title":"Deep learning applications in single-cell genomics and transcriptomics data analysis","volume":"165","author":"Erfanian","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1148\/rg.2017160130","article-title":"Machine learning for medical imaging","volume":"37","author":"Erickson","year":"2017","journal-title":"RadioGraphics"},{"key":"B65","doi-asserted-by":"publisher","first-page":"22526","DOI":"10.18632\/oncotarget.4151","article-title":"The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors","volume":"6","author":"Fazi","year":"2015","journal-title":"Oncotarget"},{"key":"B66","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","article-title":"Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review","volume":"11","author":"Fogel","year":"2018","journal-title":"Contemp. Clin. Trials Commun."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1200\/JCO.2008.19.0694","article-title":"Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study","volume":"27","author":"Galanis","year":"2009","journal-title":"JCO"},{"key":"B68","doi-asserted-by":"publisher","first-page":"101580","DOI":"10.1016\/j.esmoop.2023.101580","article-title":"Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results","volume":"8","author":"Garon","year":"2023","journal-title":"ESMO Open"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e1005308","DOI":"10.1371\/journal.pcbi.1005308","article-title":"A computational approach for identifying synergistic drug combinations","volume":"13","author":"Gayvert","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12880-020-00485-0","article-title":"Deep semi-supervised learning for brain tumor classification","volume":"20","author":"Ge","year":"2020","journal-title":"BMC Med. Imaging"},{"key":"B71","doi-asserted-by":"publisher","first-page":"107815522311675","DOI":"10.1177\/10781552231167554","article-title":"Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: perspectives of medical oncologists and oncology pharmacists","volume":"2023","author":"Glewis","year":"2023","journal-title":"J. Oncol. Pharm. Pract."},{"key":"B72","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jcph.625","article-title":"Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48\u2010hour continuous infusion in patients with cancer","volume":"56","author":"Goey","year":"2016","journal-title":"J. Clin. Pharma"},{"key":"B73","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2133\/dmpk.DMPK-10-RV-062","article-title":"Mechanisms of drug toxicity and relevance to pharmaceutical development","volume":"26","author":"Guengerich","year":"2011","journal-title":"Drug Metabolism Pharmacokinet."},{"key":"B74","doi-asserted-by":"publisher","first-page":"114518","DOI":"10.1016\/j.biopha.2023.114518","article-title":"Machine learning for genetic prediction of chemotherapy toxicity in cervical cancer","volume":"161","author":"Guo","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B75","doi-asserted-by":"publisher","first-page":"107274","DOI":"10.1016\/j.compbiomed.2023.107274","article-title":"Deep learning exploration of single-cell and spatially resolved cancer transcriptomics to unravel tumour heterogeneity","volume":"164","author":"Halawani","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/joim.12822","article-title":"eDoctor: machine learning and the future of medicine","volume":"284","author":"Handelman","year":"2018","journal-title":"J. Intern Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.tips.2019.05.005","article-title":"Artificial intelligence for clinical trial design","volume":"40","author":"Harrer","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nrd.2016.184","article-title":"Phase II and phase III failures: 2013\u20132015","volume":"15","author":"Harrison","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"B79","doi-asserted-by":"publisher","first-page":"433","DOI":"10.14348\/molcells.2021.0042","article-title":"Integrative multi-omics approaches in cancer research: from biological networks to clinical subtypes","volume":"44","author":"Heo","year":"2021","journal-title":"Mol. Cells"},{"key":"B80","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/cpt.2270","article-title":"Planning and conducting a pharmacogenetics association study","volume":"110","author":"Hertz","year":"2021","journal-title":"Clin Pharma Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13148-023-01525-6","article-title":"CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma","volume":"15","author":"Hoffmann","year":"2023","journal-title":"Clin. Epigenet"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e2300038","DOI":"10.1200\/CCI.23.00038","article-title":"Histology-based prediction of therapy response to neoadjuvant chemotherapy for esophageal and esophagogastric junction adenocarcinomas using deep learning","volume":"7","author":"H\u00f6rst","year":"2023","journal-title":"JCO Clin. Cancer Inf."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/humu.24381","article-title":"Clinical whole\u2010genome sequencing in cancer diagnosis","volume":"43","author":"Hou","year":"2022","journal-title":"Hum. Mutat."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e0186906","DOI":"10.1371\/journal.pone.0186906","article-title":"Open source machine-learning algorithms for the prediction of optimal cancer drug therapies","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS ONE"},{"key":"B85","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cell.2018.08.058","article-title":"Targeting epigenetic crosstalk as a therapeutic strategy for EZH2-aberrant solid tumors","volume":"175","author":"Huang","year":"2018","journal-title":"Cell"},{"key":"B86","doi-asserted-by":"publisher","first-page":"153760","DOI":"10.1016\/j.prp.2022.153760","article-title":"The emerging roles of NGS in clinical oncology and personalized medicine","volume":"230","author":"Hussen","year":"2022","journal-title":"Pathology - Res. Pract."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1001\/jamainternmed.2016.6008","article-title":"Failure of investigational drugs in late-stage clinical development and publication of trial results","volume":"176","author":"Hwang","year":"2016","journal-title":"JAMA Intern Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.292.5518.929","article-title":"Integrated genomic and proteomic analyses of a systematically perturbed metabolic network","volume":"292","author":"Ideker","year":"2001","journal-title":"Science"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1200\/JCO.2004.07.173","article-title":"Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan","volume":"22","author":"Innocenti","year":"2004","journal-title":"JCO"},{"key":"B90","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/01.MXE.0000415225.85003.47","article-title":"Genetic polymorphism studies in humans: Middle East","volume":"1","author":"Ismail","year":"2012","journal-title":"J. Med. Genet."},{"key":"B91","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/sj.tpj.6500072","article-title":"UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity","volume":"2","author":"Iyer","year":"2002","journal-title":"Pharmacogenomics J."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.3390\/diagnostics13142460","article-title":"A review of machine learning techniques for the classification and detection of breast cancer from medical images","volume":"13","author":"Jalloul","year":"2023","journal-title":"Diagnostics"},{"key":"B93","volume-title":"An introduction to statistical learning: with applications in R","author":"G.","year":"2013"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/cpt.2095","article-title":"Effects of NT5C2 germline variants on 6\u2010mecaptopurine metabolism in children with acute lymphoblastic leukemia","volume":"109","author":"Jiang","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"B95","doi-asserted-by":"publisher","first-page":"bbac100","DOI":"10.1093\/bib\/bbac100","article-title":"DeepTTA: a transformer-based model for predicting cancer drug response","volume":"23","author":"Jiang","year":"2022","journal-title":"Briefings Bioinforma."},{"key":"B96","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1038\/s41467-020-18742-9","article-title":"Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy","volume":"11","author":"Jing","year":"2020","journal-title":"Nat. Commun."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1038\/onc.2011.474","article-title":"Acquired MET expression confers resistance to EGFR inhibition in a mouse model of glioblastoma multiforme","volume":"31","author":"Jun","year":"2012","journal-title":"Oncogene"},{"key":"B98","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.semradonc.2023.06.004","article-title":"Integrating artificial intelligence and machine learning into cancer clinical trials","volume":"33","author":"Kang","year":"2023","journal-title":"Seminars Radiat. Oncol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.3390\/ijms21082825","article-title":"Synergistic effects of combination therapy with AKT and mTOR inhibitors on bladder cancer cells","volume":"21","author":"Kim","year":"2020","journal-title":"IJMS"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/neuonc\/noad036","article-title":"A critical analysis of neuro-oncology clinical trials","volume":"25","author":"Kim","year":"2023","journal-title":"Neuro Oncol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.1135308","article-title":"A \u201csilent\u201d polymorphism in the MDR 1 gene changes substrate specificity","volume":"315","author":"Kimchi-Sarfaty","year":"2007","journal-title":"Science"},{"key":"B102","doi-asserted-by":"publisher","first-page":"100015","DOI":"10.1016\/j.modpat.2022.100015","article-title":"A deep neural network\u2013based decision support tool for the detection of lymph node metastases in colorectal cancer specimens","volume":"36","author":"Kindler","year":"2023","journal-title":"Mod. Pathol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41746-022-00712-8","article-title":"Multimodal machine learning in precision health: a scoping review","volume":"5","author":"Kline","year":"2022","journal-title":"npj Digit. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/FTD.0000000000000701","article-title":"Cancer chemotherapy: the case for therapeutic drug monitoring","volume":"42","author":"Knezevic","year":"2020","journal-title":"Ther. Drug Monit."},{"key":"B105","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1023\/A:1025806911782","article-title":"Epigenetic changes in colorectal cancer","volume":"23","author":"Kondo","year":"2004","journal-title":"Cancer Metastasis Rev."},{"key":"B106","doi-asserted-by":"publisher","first-page":"100517","DOI":"10.1016\/j.crmeth.2023.100517","article-title":"MIA is an open-source standalone deep learning application for microscopic image analysis","volume":"3","author":"K\u00f6rber","year":"2023","journal-title":"Cell Rep. Methods"},{"key":"B107","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/jpm11010032","article-title":"How do machines learn? Artificial intelligence as a new era in medicine","volume":"11","author":"Koteluk","year":"2021","journal-title":"JPM"},{"key":"B108","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","article-title":"Machine learning applications in cancer prognosis and prediction","volume":"13","author":"Kourou","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B109","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"B110","doi-asserted-by":"publisher","first-page":"R231","DOI":"10.1016\/j.cub.2019.02.034","article-title":"Neural network models and deep learning","volume":"29","author":"Kriegeskorte","year":"2019","journal-title":"Curr. Biol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/CAD.0000000000001360","article-title":"Association of genetic polymorphisms of CYP3A4 and CYP2D6 with gefitinib-induced toxicities","volume":"33","author":"Kwok","year":"2022","journal-title":"Anti-Cancer Drugs"},{"key":"B112","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2164-16-S9-S4","article-title":"Integrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer","volume":"16","author":"Kwon","year":"2015","journal-title":"BMC Genomics"},{"key":"B113","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/B978-0-12-817193-6.00002-9","article-title":"Non-coding RNAs: ever-expanding diversity of types and functions","volume":"19","author":"Lakhotia","year":"2020","journal-title":"Rna-Based Regul. Hum. Health Dis."},{"key":"B114","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"B115","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1208\/s12248-017-0161-x","article-title":"Pharmacogenomic biomarkers for improved drug therapy\u2014recent progress and future developments","volume":"20","author":"Lauschke","year":"2018","journal-title":"AAPS J."},{"key":"B116","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"LeCun","year":"2015","journal-title":"Nature"},{"key":"B117","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13058-019-1204-2","article-title":"Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51","volume":"21","author":"Lee","year":"2019","journal-title":"Breast Cancer Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.pcl.2023.06.001","article-title":"Panels, exomes, genomes, and more\u2014finding the best path through the diagnostic odyssey","volume":"70","author":"Lenahan","year":"2023","journal-title":"Pediatr. Clin. N. Am."},{"key":"B119","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2217\/pgs-2022-0135","article-title":"DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand?","volume":"24","author":"Le\u0161njakovi\u0107","year":"2023","journal-title":"Pharmacogenomics"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1158\/1078-0432.CCR-23-0797","article-title":"Identifying mechanisms of resistance by circulating tumor DNA in EVOLVE, a phase II trial of cediranib plus olaparib for ovarian cancer at time of PARP inhibitor progression","volume":"29","author":"Lheureux","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/abt\/tbac014","article-title":"Strategies to mitigate the on- and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective","volume":"5","author":"Li","year":"2022","journal-title":"Antib. Ther."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11030-022-10466-w","article-title":"Classification models and SAR analysis on HDAC1 inhibitors using machine learning methods","volume":"27","author":"Li","year":"2023","journal-title":"Mol. Divers"},{"key":"B123","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41368-021-00146-0","article-title":"From bulk, single-cell to spatial RNA sequencing","volume":"13","author":"Li","year":"2021","journal-title":"Int. J. Oral Sci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1093\/neuonc\/noac204","article-title":"EGFR, the Lazarus target for precision oncology in glioblastoma","volume":"24","author":"Lin","year":"2022","journal-title":"Neuro-Oncology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/s41436-021-01187-w","article-title":"One in seven pathogenic variants can be challenging to detect by NGS: an analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation","volume":"23","author":"Lincoln","year":"2021","journal-title":"Genet. Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/gim.2017.119","article-title":"Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test","volume":"20","author":"Lionel","year":"2018","journal-title":"Genet. Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1032623","DOI":"10.3389\/fmicb.2022.1032623","article-title":"A multi-omics machine learning framework in predicting the recurrence and metastasis of patients with pancreatic adenocarcinoma","volume":"13","author":"Li S","year":"2022","journal-title":"Front. Microbiol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"e1010529","DOI":"10.1371\/journal.pcbi.1010529","article-title":"Identification of key somatic oncogenic mutation based on a confounder-free causal inference model","volume":"18","author":"Liu","year":"2022","journal-title":"PLoS Comput. Biol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"989275","DOI":"10.3389\/fimmu.2022.989275","article-title":"Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/cam4.3691","article-title":"Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer","volume":"10","author":"Loukovaara","year":"2021","journal-title":"Cancer Med."},{"key":"B132","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/B978-0-12-385471-1.00020-9","article-title":"Dose\u2013effect and concentration\u2013effect analysis","volume-title":"Principles of clinical pharmacology","author":"Lowe","year":"2012"},{"key":"B133","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/metabo12060494","article-title":"Discovery of synergistic drug combinations for colorectal cancer driven by tumor barcode derived from metabolomics \u201cbig data.\u201d","volume":"12","author":"Lv","year":"2022","journal-title":"Metabolites"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non\u2013small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12859-022-04664-4","article-title":"DualGCN: a dual graph convolutional network model to predict cancer drug response","volume":"23","author":"Ma","year":"2022","journal-title":"BMC Bioinforma."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.21873\/anticanres.16275","article-title":"Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib metabolites (M2, M20, M18)","volume":"43","author":"Maeda","year":"2023","journal-title":"Anticancer Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"B138","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.trecan.2019.11.006","article-title":"Evolving significance of tumor-normal sequencing in cancer care","volume":"6","author":"Mandelker","year":"2020","journal-title":"Trends Cancer"},{"key":"B139","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-21-0327","article-title":"FDA approval summary: pembrolizumab for the treatment of tumor mutational burden\u2013high solid tumors","volume":"27","author":"Marcus","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"B140","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12943-023-01832-9","article-title":"REGISTRI: regorafenib in first-line of KIT\/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial","volume":"22","author":"Martin-Broto","year":"2023","journal-title":"Mol. Cancer"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s12553-022-00708-0","article-title":"Regulatory considerations on the use of machine learning based tools in clinical trials","volume":"12","author":"Massella","year":"2022","journal-title":"Health Technol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"541281","DOI":"10.3389\/fonc.2020.541281","article-title":"A deep learning approach validates genetic risk factors for late toxicity after prostate cancer radiotherapy in a REQUITE multi-national cohort","volume":"10","author":"Massi","year":"2020","journal-title":"Front. Oncol."},{"key":"B143","first-page":"3246","article-title":"Irinotecan pathway genotype analysis to predict pharmacokinetics","volume":"9","author":"Mathijssen","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.annonc.2021.02.006","article-title":"High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types","volume":"32","author":"McGrail","year":"2021","journal-title":"Ann. Oncol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41416-023-02398-5","article-title":"Redefining precision radiotherapy through liquid biopsy","volume":"129","author":"McLaren","year":"2023","journal-title":"Br. J. Cancer"},{"key":"B146","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00439-015-1631-9","article-title":"Clinical sequencing: is WGS the better WES?","volume":"135","author":"Meienberg","year":"2016","journal-title":"Hum. Genet."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/neuonc\/noab294","article-title":"Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases","volume":"24","author":"Mei\u00dfner","year":"2022","journal-title":"Neuro-Oncology"},{"key":"B148","doi-asserted-by":"publisher","first-page":"e61318","DOI":"10.1371\/journal.pone.0061318","article-title":"Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties","volume":"8","author":"Menden","year":"2013","journal-title":"PLoS ONE"},{"key":"B149","doi-asserted-by":"publisher","first-page":"110402","DOI":"10.1016\/j.intimp.2023.110402","article-title":"The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer","volume":"121","author":"Meng","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"e000147","DOI":"10.1136\/jitc-2019-000147","article-title":"Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project","volume":"8","author":"Merino","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"B151","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1017\/S0033291715002305","article-title":"Latent variable mixture modeling in psychiatric research \u2013 a review and application","volume":"46","author":"Miettunen","year":"2016","journal-title":"Psychol. Med."},{"key":"B152","article-title":"Machine learning, nachdr","volume-title":"McGraw-hill series in computer science","author":"Mitchell","year":"2013"},{"key":"B153","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/s41591-023-02482-6","article-title":"Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary","volume":"29","author":"Moon","year":"2023","journal-title":"Nat. Med."},{"key":"B154","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1158\/1535-7163.MCT-06-0327","article-title":"Clinical relevance of different dihydropyrimidine dehydrogenase gene single nucleotide polymorphisms on 5-fluorouracil tolerance","volume":"5","author":"Morel","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"B155","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/ng.3508","article-title":"NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity","volume":"48","author":"Moriyama","year":"2016","journal-title":"Nat. Genet."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/s41436-018-0397-6","article-title":"Detection of structural variation using target captured next-generation sequencing data for genetic diagnostic testing","volume":"21","author":"Mu","year":"2019","journal-title":"Genet. Med."},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3152","article-title":"Current status and future directions: the application of artificial intelligence\/machine learning (AI\/ML) for precision medicine","volume":"3152","author":"Naik","year":"2023","journal-title":"Clin Pharma Ther. cpt"},{"key":"B158","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1034\/j.1399-0004.1999.560401.x","article-title":"Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist? pharmacogenetics and pharmacogenomics","volume":"56","author":"Nebert","year":"1999","journal-title":"Clin. Genet."},{"key":"B159","doi-asserted-by":"publisher","first-page":"e1000888","DOI":"10.1371\/journal.pgen.1000888","article-title":"Trait-associated SNPs are more likely to Be eQTLs: annotation to enhance discovery from GWAS","volume":"6","author":"Nicolae","year":"2010","journal-title":"PLoS Genet."},{"key":"B160","doi-asserted-by":"publisher","first-page":"16224","DOI":"10.1111\/imj.16224","article-title":"Utility of multigene panel next\u2010generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer","volume":"2023","author":"Nindra","year":"2023","journal-title":"Intern. Med. J. imj"},{"key":"B161","doi-asserted-by":"publisher","first-page":"23545","DOI":"10.1038\/s41598-021-02910-y","article-title":"Quantum deep reinforcement learning for clinical decision support in oncology: application to adaptive radiotherapy","volume":"11","author":"Niraula","year":"2021","journal-title":"Sci. Rep."},{"key":"B162","doi-asserted-by":"publisher","first-page":"bbad120","DOI":"10.1093\/bib\/bbad120","article-title":"Machine learning for synergistic network pharmacology: a comprehensive overview","volume":"24","author":"Noor","year":"2023","journal-title":"Briefings Bioinforma."},{"key":"B163","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1124\/dmd.104.001909","article-title":"Role of organic anion transporter Oatp1b1 (oatp-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms","volume":"33","author":"Nozawa","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"B164","doi-asserted-by":"publisher","first-page":"102066","DOI":"10.1016\/j.ejon.2021.102066","article-title":"Development of a prediction models for chemotherapy-induced adverse drug reactions: a retrospective observational study using electronic health records","volume":"56","author":"On","year":"2022","journal-title":"Eur. J. Oncol. Nurs."},{"key":"B165","article-title":"Soft tissue and bone tumours","volume-title":"World health organization classification of tumours","year":"2020"},{"key":"B166","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/pr8060638","article-title":"Measuring performance metrics of machine learning algorithms for detecting and classifying transposable elements","volume":"8","author":"Orozco-Arias","year":"2020","journal-title":"Transposable Elem. Process."},{"key":"B167","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.3390\/diagnostics13132145","article-title":"Diagnostic accuracy of machine learning ai architectures in detection and classification of lung cancer: a systematic review","volume":"13","author":"Pacurari","year":"2023","journal-title":"Diagnostics"},{"key":"B168","doi-asserted-by":"publisher","first-page":"11911","DOI":"10.1038\/s41598-023-39179-2","article-title":"A performance evaluation of drug response prediction models for individual drugs","volume":"13","author":"Park","year":"2023","journal-title":"Sci. Rep."},{"key":"B169","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1200\/JCO.21.02838","article-title":"Actionable tumor alterations and treatment protocol enrollment of pediatric and young adult patients with refractory cancers in the national cancer institute\u2013children\u2019s oncology group pediatric MATCH trial","volume":"40","author":"Parsons","year":"2022","journal-title":"JCO"},{"key":"B170","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1097\/MS9.0000000000001061","article-title":"Circulating miR-221\/222 expression as microRNA biomarker predicting tamoxifen treatment outcome: a case\u2013control study","volume":"85","author":"Patellongi","year":"2023","journal-title":"Ann. Med. Surg."},{"key":"B171","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","article-title":"Innovation: metabolomics: the apogee of the omics trilogy","volume":"13","author":"Patti","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2217\/pgs-2023-0096","article-title":"UGT1A1 genotype-guided dosing of irinotecan: time to prioritize patient safety","volume":"24","author":"Peeters","year":"2023","journal-title":"Pharmacogenomics"},{"key":"B173","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature15520","article-title":"Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy","volume":"527","author":"Peng","year":"2015","journal-title":"Nature"},{"key":"B174","doi-asserted-by":"publisher","first-page":"100637","DOI":"10.1016\/j.esmoop.2022.100637","article-title":"COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy","volume":"7","author":"Pixberg","year":"2022","journal-title":"ESMO Open"},{"key":"B175","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1023\/A:1016409317640","article-title":"Decision trees: an overview and their use in medicine","volume":"26","author":"Podgorelec","year":"2002","journal-title":"J. Med. Syst."},{"key":"B176","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1002\/cpt.2960","article-title":"Machine learning application identifies germline markers of hypertension in ovarian cancer patients treated with carboplatin, taxane and bevacizumab","volume":"2023","author":"Polano","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"B177","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B178","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41397-022-00279-3","article-title":"KDR genetic predictor of toxicities induced by sorafenib and regorafenib","volume":"22","author":"Quintanilha","year":"","journal-title":"Pharmacogenomics J."},{"key":"B179","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/ijc.33810","article-title":"Genome\u2010wide association studies of survival in 1520 cancer patients treated with bevacizumab\u2010containing regimens","volume":"150","author":"Quintanilha","year":"","journal-title":"Intl J. Cancer"},{"key":"B180","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12032-022-01924-4","article-title":"Machine learning driven drug repurposing strategy for identification of potential RET inhibitors against non-small cell lung cancer","volume":"40","author":"Ramesh","year":"2022","journal-title":"Med. Oncol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/cpt.1304","article-title":"Clinical pharmacogenetics implementation Consortium guideline for thiopurine dosing based on TPMT and NUDT 15 genotypes: 2018 update","volume":"105","author":"Relling","year":"2019","journal-title":"Clin Pharma Ther."},{"key":"B182","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/cjp2.294","article-title":"A prognostic six\u2010gene expression risk\u2010score derived from proteomic profiling of the metastatic colorectal cancer secretome","volume":"8","author":"Robles","year":"2022","journal-title":"J. Pathology CR"},{"key":"B183","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0140-6736(19)31276-0","article-title":"Pharmacogenomics","volume":"394","author":"Roden","year":"2019","journal-title":"Lancet"},{"key":"B184","doi-asserted-by":"publisher","first-page":"e2072","DOI":"10.1002\/mgg3.2072","article-title":"Scalable detection of technically challenging variants through modified next\u2010generation sequencing","volume":"10","author":"Rojahn","year":"2022","journal-title":"Molec Gen Gen Med"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1093\/annonc\/mdr483","article-title":"Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients","volume":"23","author":"Romero","year":"2012","journal-title":"Ann. Oncol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41698-023-00428-2","article-title":"Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers","volume":"7","author":"Romero","year":"2023","journal-title":"npj Precis. Onc."},{"key":"B187","doi-asserted-by":"publisher","first-page":"105001","DOI":"10.1016\/j.compbiomed.2021.105001","article-title":"Survival analysis with semi-supervised predictive clustering trees","volume":"141","author":"Roy","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"B188","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/0192623312464311","article-title":"On-target and off-target-based toxicologic effects","volume":"41","author":"Rudmann","year":"2013","journal-title":"Toxicol. Pathol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"15930","DOI":"10.1111\/bcp.15930","article-title":"Artificial intelligence and machine learning for clinical pharmacology","volume":"2023","author":"Ryan","year":"2023","journal-title":"Brit J. Clin. Pharma bcp"},{"key":"B190","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev.bioeng.8.061505.095802","article-title":"Machine learning for detection and diagnosis of disease","volume":"8","author":"Sajda","year":"2006","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"B191","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32074\/1591-951X-213","article-title":"The 2020 WHO classification of soft tissue tumours: news and perspectives","volume":"113","author":"Sbaraglia","year":"2020","journal-title":"Pathologica"},{"key":"B192","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/s41431-021-00834-9","article-title":"The impact of unsolicited findings in clinical exome sequencing, a qualitative interview study","volume":"29","author":"Schoot","year":"2021","journal-title":"Eur. J. Hum. Genet."},{"key":"B193","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1200\/JCO.2007.12.2705","article-title":"Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes","volume":"25","author":"Schroth","year":"2007","journal-title":"JCO"},{"key":"B194","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1016\/j.molcel.2021.08.034","article-title":"NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis","volume":"81","author":"Sengupta","year":"2021","journal-title":"Mol. Cell"},{"key":"B195","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jmoldx.2016.11.001","article-title":"Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American society for clinical pathology, college of American pathologists, association for molecular pathology, and American society of clinical oncology","volume":"19","author":"Sepulveda","year":"2017","journal-title":"J. Mol. Diagnostics"},{"key":"B196","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/cpt.3083","article-title":"Artificial intelligence: from buzzword to useful tool in clinical pharmacology","volume":"2023","author":"Shahin","year":"2023","journal-title":"Clin Pharma Ther. cpt"},{"key":"B197","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jamaneurol.2013.3682","article-title":"From genome-wide association studies to next-generation sequencing: lessons from the past and planning for the future","volume":"71","author":"Sharma","year":"2014","journal-title":"JAMA Neurol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/stmcls\/sxad057","article-title":"Uncovering the heterogeneity of cardiac lin \u2013KIT + cells: a scRNA-seq study on the identification of subpopulations","volume":"41","author":"Shen","year":"2023","journal-title":"Stem Cells"},{"key":"B199","doi-asserted-by":"publisher","first-page":"bbaa249","DOI":"10.1093\/bib\/bbaa249","article-title":"Prognostic outcome prediction by semi-supervised least squares classification","volume":"22","author":"Shi","year":"2021","journal-title":"Briefings Bioinforma."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1158\/0008-5472.CAN-20-2222","article-title":"Multiomics characterization of low-grade serous ovarian carcinoma identifies potential biomarkers of MEK inhibitor sensitivity and therapeutic vulnerability","volume":"81","author":"Shrestha","year":"2021","journal-title":"Cancer Res."},{"key":"B201","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrg3642","article-title":"Sequencing depth and coverage: key considerations in genomic analyses","volume":"15","author":"Sims","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"B202","volume-title":"Optimization for machine learning, Neural information processing series","author":"Sra","year":"2012"},{"key":"B203","first-page":"430","article-title":"Revisions to the JDL data fusion model","volume-title":"Presented at the AeroSense \u201999","author":"Steinberg","year":"1999"},{"key":"B204","doi-asserted-by":"publisher","first-page":"eabm5386","DOI":"10.1126\/sciadv.abm5386","article-title":"Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing","volume":"8","author":"Stevanovski","year":"2022","journal-title":"Sci. Adv."},{"key":"B205","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jmoldx.2022.12.004","article-title":"CANTRK: a Canadian ring study to optimize detection of NTRK gene fusions by next-generation RNA sequencing","volume":"25","author":"Stockley","year":"2023","journal-title":"J. Mol. Diagnostics"},{"key":"B206","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/ijc.10896","article-title":"Association between a glutathioneS-transferase A1 promoter polymorphism and survival after breast cancer treatment","volume":"103","author":"Sweeney","year":"2003","journal-title":"Int. J. Cancer"},{"key":"B207","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0140-6736(22)01841-4","article-title":"A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study","volume":"401","author":"Swen","year":"2023","journal-title":"Lancet"},{"key":"B208","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fgene.2019.00256","article-title":"A machine learning approach for identifying gene biomarkers guiding the treatment of breast cancer","volume":"10","author":"Tabl","year":"2019","journal-title":"Front. Genet."},{"key":"B209","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.canrad.2023.05.001","article-title":"Prediction of toxicity outcomes following radiotherapy using deep learning-based models: a systematic review","volume":"27","author":"Tan","year":"2023","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"B210","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/mas.20356","article-title":"Cancer proteomics: CANCER PROTEOMICS","volume":"31","author":"Tan","year":"2012","journal-title":"Mass Spectrom. Rev."},{"key":"B211","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/jmg-2022-108582","article-title":"Early breast cancer risk detection: a novel framework leveraging polygenic risk scores and machine learning","volume":"60","author":"Tao","year":"2023","journal-title":"J. Med. Genet. jmedgenet-"},{"key":"B212","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/nbm.1016","article-title":"Development of a decision support system for diagnosis and grading of brain tumours usingin vivo magnetic resonance single voxel spectra","volume":"19","author":"Tate","year":"2006","journal-title":"NMR Biomed."},{"key":"B213","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome Atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat. Genet."},{"key":"B214","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1349-7006.2012.02215.x","article-title":"Elevated level of lysine 9-acetylated histone H3 at the MDR1 promoter in multidrug-resistant cells","volume":"103","author":"Toth","year":"2012","journal-title":"Cancer Sci."},{"key":"B215","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrg3117","article-title":"Repetitive DNA and next-generation sequencing: computational challenges and solutions","volume":"13","author":"Treangen","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"B216","doi-asserted-by":"publisher","first-page":"i601","DOI":"10.1093\/bioinformatics\/btaa799","article-title":"RAINFOREST: a random forest approach to predict treatment benefit in data from (failed) clinical drug trials","volume":"36","author":"Ubels","year":"2020","journal-title":"Bioinformatics"},{"key":"B217","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43586-021-00056-9","article-title":"Genome-wide association studies","volume":"1","author":"Uffelmann","year":"2021","journal-title":"Nat. Rev. Methods Prim."},{"key":"B218","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/cts.13431","article-title":"Artificial intelligence in pharmacology research and practice","volume":"16","author":"Van Der Lee","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"B219","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/msb.2010.59","article-title":"Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line","volume":"6","author":"Vogel","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/FPC.0b013e3283352860","article-title":"Very important pharmacogene summary: thiopurine S-methyltransferase","volume":"20","author":"Wang","year":"2010","journal-title":"Pharmacogenetics Genomics"},{"key":"B221","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.semcancer.2018.04.008","article-title":"Statistical methods for genome-wide association studies","volume":"55","author":"Wang","year":"2019","journal-title":"Seminars Cancer Biol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/bjh.18851","article-title":"Germline Neurofibromin 1 mutation enhances the anti\u2010tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity","volume":"202","author":"Wang","year":"2023","journal-title":"Br. J. Haematol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1016\/j.cell.2021.09.006","article-title":"In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target","volume":"184","author":"Wang","year":"2021","journal-title":"Cell"},{"key":"B224","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-022-01631-8","article-title":"A two-stage genome-wide association study to identify novel genetic loci associated with acute radiotherapy toxicity in nasopharyngeal carcinoma","volume":"21","author":"Wang","year":"2022","journal-title":"Mol. Cancer"},{"key":"B225","doi-asserted-by":"publisher","first-page":"bbab048","DOI":"10.1093\/bib\/bbab048","article-title":"DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration","volume":"22","author":"Wang","year":"2021","journal-title":"Briefings Bioinforma."},{"key":"B226","doi-asserted-by":"publisher","first-page":"13383","DOI":"10.1007\/s00432-023-05196-x","article-title":"Early clinical trial unit tumor board: a real-world experience in a national cancer network","volume":"149","author":"Weiss","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"208625","DOI":"10.1136\/jcp-2022-208625","article-title":"Implementation of an ISO15189 accredited next-generation sequencing service with the fully automated Ion Torrent Genexus: the experience of a clinical diagnostic laboratory","volume":"2022","author":"Werner","year":"2022","journal-title":"J. Clin. Pathol. jcp"},{"key":"B228","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/biostatistics\/kxy072","article-title":"Corrigendum: estimation of clinical trial success rates and related parameters","volume":"20","author":"Wong","year":"2019","journal-title":"Biostatistics"},{"key":"B229","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s40520-023-02552-2","article-title":"A comprehensive review of machine learning algorithms and their application in geriatric medicine: present and future","volume":"35","author":"Woodman","year":"2023","journal-title":"Aging Clin. Exp. Res."},{"key":"B230","first-page":"5457","article-title":"DNA methylation of hMLH1 correlates with the clinical response to cisplatin after a surgical resection in Non-small cell lung cancer","volume":"8","author":"Wu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B231","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/bcp.12675","article-title":"Interindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjects: interindividual epigenetic variation in ABCB1 in healthy Chinese subjects","volume":"80","author":"Wu","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1021\/acssensors.3c00126","article-title":"NanoBeacon.AI: AI-enhanced nanodiamond biosensor for automated sensitivity prediction to oxidative phosphorylation inhibitors","volume":"8","author":"Xu","year":"2023","journal-title":"ACS Sens."},{"key":"B233","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"B234","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1002\/1878-0261.13067","article-title":"A comprehensive analysis of SNPs and CNVs identifies novel markers associated with disease outcomes in colorectal cancer","volume":"15","author":"Yu","year":"2021","journal-title":"Mol. Oncol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"893966","DOI":"10.3389\/fonc.2022.893966","article-title":"Predicting lapatinib dose regimen using machine learning and deep learning techniques based on a real-world study","volume":"12","author":"Yu","year":"2022","journal-title":"Front. Oncol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1039\/C9SC04336E","article-title":"Target identification among known drugs by deep learning from heterogeneous networks","volume":"11","author":"Zeng","year":"2020","journal-title":"Chem. Sci."},{"key":"B237","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s11523-023-00985-3","article-title":"A retrospective analysis of biliary tract cancer patients presented to the molecular tumor board at the comprehensive cancer center munich","volume":"18","author":"Zhang","year":"2023","journal-title":"Targ. Oncol."},{"key":"B238","doi-asserted-by":"publisher","first-page":"116994","DOI":"10.1016\/j.bmc.2022.116994","article-title":"Ligand- and structure-based identification of novel CDK9 inhibitors for the potential treatment of leukemia","volume":"72","author":"Zhang","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"B239","doi-asserted-by":"publisher","first-page":"bar026","DOI":"10.1093\/database\/bar026","article-title":"International cancer genome Consortium data portal--a one-stop shop for cancer genomics data","volume":"2011","author":"Zhang","year":"2011","journal-title":"Database"},{"key":"B240","doi-asserted-by":"publisher","first-page":"107247","DOI":"10.1016\/j.compbiomed.2023.107247","article-title":"DeepTAP: an RNN-based method of TAP-binding peptide prediction in the selection of tumor neoantigens","volume":"164","author":"Zhang","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"B241","doi-asserted-by":"publisher","first-page":"28913","DOI":"10.1002\/jmri.28913","article-title":"Multitask deep learning-based whole-process system for automatic diagnosis of breast lesions and axillary lymph node metastasis discrimination from dynamic contrast\u2010enhanced\u2010 mri: a multicenter study","volume":"2023","author":"Zhou","year":"2023","journal-title":"Magn. Reson. Imaging jmri"},{"key":"B242","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13148-022-01363-y","article-title":"Association of H3K9me3 with breast cancer prognosis by estrogen receptor status","volume":"14","author":"Zhou","year":"2022","journal-title":"Clin. Epigenet"},{"key":"B243","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12859-022-04720-z","article-title":"Machine learning approach informs biology of cancer drug response","volume":"23","author":"Zhu","year":"2022","journal-title":"BMC Bioinforma."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1260276\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T04:13:01Z","timestamp":1704773581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1260276\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":243,"alternative-id":["10.3389\/fphar.2023.1260276"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1260276","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"article-number":"1260276"}}